2006P-0511
  

  
 Stay any action to grant approval for Oxycodone Hydrochloride extended release tablets, ANDA 77-822

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3
  



  

  
Submitter : 
  

  
Ms. Karla  Iverson
  

  
Date & Time: 
  

  
01/19/2007 10:01:33
  



  

  
Organization : 
  

  
Ms. Karla  Iverson
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 As both a health professional and a person with Fibromyalgia, I question  withholding approval for the extended release formula for pain medication that is already on the market.  As you may or may not know, if pain relief can be provided in measured doses for an extended period of time, the person who lives with chronic pain has a higher quality of life. If this product is faulty, then please do withhold approval.  However, if it works, most of us who have chronic pain would appreciate taking fewer pills that last longer.